Valneva rises after U.K. approval of chikungunya vaccine

Shares of Valneva (NASDAQ:VALN) traded higher on Wednesday after the French biotech announced that the U.K.’s Medicines and Healthcare Products Regulatory Agency granted marketing authorization for its chikungunya vaccine.

Accordingly, the single-shot vaccine branded as Ixchiq will be indicated in the